l  General Information  | 
Product Name  | CCG-222740  | 
General description  | Nanocarrier CCG-222740 significantly decreased ACTA2 gene and was not cytotoxic in human conjunctival fibroblasts.  | 
Purity  | ≥98.0%(HPLC)  | CAS Number  | 1922098-69-8  | 
Formula  | C23H19ClF2N2O3  | Molecular Weight  | 444.865  | 
Suitability  | BioReagent, suitable for cell culture, etc.  | 
l  Physical and Chemical Information  | 
Appearance  | Off-white or beige powder  | 
Solubility(25°C)  | DMSO  | ≥25mg/mL  | 
Ethanol  | ≥25mg/mL  | 
Water  | Insoluble  | 
l  Biological Information  | 
Biochem/Physiol
  Actions  | CCG-222740 is a potent and selective Rho/myocardin-related transcription factor (MRTF) pathway inhibitor.CCG-222740 also is a potent inhibitor of alpha-smooth muscle actin protein. CCG-222740 effectively reduces fibrosis in skin and blocks melanoma metastasis.  | 
l  Storage  | 
Storage temp.  | -20°C  | 
l  Precautions and Disclaimer  | 
This product is for R&D use only, not
  for drug, household, or other uses.  | 
l  References  | 
1.    http://www.drugbank.ca 2.    https://ncit.nci.nih.gov 3.    https://www.ncbi.nlm.nih.gov  |